An experimental study was conducted in a sieve tray column. This study used a simulated flue gas consisting of 30% CO and 70%. A 10% mass fraction of methyl diethanolamine (MDEA) aqueous solution was used as a solvent.
View Article and Find Full Text PDFContext: Systemic treatment of metastatic renal cell carcinoma (mRCC) with targeted therapies became widely accepted; however, there are few patients who greatly benefit from immunochemotherapy (ICT). It is crucial to recognize these patients for individual treatment.
Objectives: Definition of protein patterns in tissue and serum from mRCC-patients to predict benefit from ICT.